Belkaya Serkan, Kontorovich Amy R, Byun Minji, Mulero-Navarro Sonia, Bajolle Fanny, Cobat Aurelie, Josowitz Rebecca, Itan Yuval, Quint Raphaelle, Lorenzo Lazaro, Boucherit Soraya, Stoven Cecile, Di Filippo Sylvie, Abel Laurent, Zhang Shen-Ying, Bonnet Damien, Gelb Bruce D, Casanova Jean-Laurent
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York.
Departments of Pediatrics and Genetics and Genomic Sciences, The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
J Am Coll Cardiol. 2017 Apr 4;69(13):1653-1665. doi: 10.1016/j.jacc.2017.01.043.
Myocarditis is inflammation of the heart muscle that can follow various viral infections. Why children only rarely develop life-threatening acute viral myocarditis (AVM), given that the causal viral infections are common, is unknown. Genetic lesions might underlie such susceptibilities. Mouse genetic studies demonstrated that interferon (IFN)-α/β immunity defects increased susceptibility to virus-induced myocarditis. Moreover, variations in human TLR3, a potent inducer of IFNs, were proposed to underlie AVM.
This study sought to evaluate the hypothesis that human genetic factors may underlie AVM in previously healthy children.
We tested the role of TLR3-IFN immunity using human induced pluripotent stem cell-derived cardiomyocytes. We then performed whole-exome sequencing of 42 unrelated children with acute myocarditis (AM), some with proven viral causes.
We found that TLR3- and STAT1-deficient cardiomyocytes were not more susceptible to Coxsackie virus B3 (CVB3) infection than control cells. Moreover, CVB3 did not induce IFN-α/β and IFN-α/β-stimulated genes in control cardiomyocytes. Finally, exogenous IFN-α did not substantially protect cardiomyocytes against CVB3. We did not observe a significant enrichment of rare variations in TLR3- or IFN-α/β-related genes. Surprisingly, we found that homozygous but not heterozygous rare variants in genes associated with inherited cardiomyopathies were significantly enriched in AM-AVM patients compared with healthy individuals (p = 2.22E-03) or patients with other diseases (p = 1.08E-04). Seven of 42 patients (16.7%) carried rare biallelic (homozygous or compound heterozygous) nonsynonymous or splice-site variations in 6 cardiomyopathy-associated genes (BAG3, DSP, PKP2, RYR2, SCN5A, or TNNI3).
Previously silent recessive defects of the myocardium may predispose to acute heart failure presenting as AM, notably after common viral infections in children.
心肌炎是一种可继发于多种病毒感染后的心肌炎症。鉴于引发心肌炎的病毒感染很常见,但儿童却很少发生危及生命的急性病毒性心肌炎(AVM),其原因尚不清楚。遗传损伤可能是导致这种易感性的基础。小鼠遗传学研究表明,干扰素(IFN)-α/β免疫缺陷会增加对病毒诱导的心肌炎的易感性。此外,有人提出人类Toll样受体3(TLR3)(一种强大的IFN诱导剂)的变异是AVM的基础。
本研究旨在评估人类遗传因素可能是先前健康儿童发生AVM的基础这一假说。
我们利用人诱导多能干细胞衍生的心肌细胞测试了TLR3-IFN免疫的作用。然后,我们对42名患有急性心肌炎(AM)的无关儿童进行了全外显子组测序,其中一些儿童的病因已证实为病毒感染。
我们发现,与对照细胞相比,TLR3和信号转导和转录激活因子1(STAT1)缺陷的心肌细胞对柯萨奇病毒B3(CVB3)感染并不更易感。此外,CVB3在对照心肌细胞中并未诱导IFN-α/β和IFN-α/β刺激基因。最后,外源性IFN-α并不能显著保护心肌细胞免受CVB3感染。我们没有观察到TLR3或IFN-α/β相关基因中罕见变异的显著富集。令人惊讶的是,我们发现与遗传性心肌病相关基因中的纯合而非杂合罕见变异在AM-AVM患者中与健康个体相比有显著富集(p = 2.22E-03),与其他疾病患者相比也有显著富集(p = 1.08E-04)。42名患者中有7名(16.7%)在6个心肌病相关基因(BAG3、桥粒斑蛋白(DSP)、桥粒芯蛋白2(PKP2)、兰尼碱受体2(RYR2)、钠通道蛋白5A(SCN5A)或肌钙蛋白I3(TNNI3))中携带罕见的双等位基因(纯合或复合杂合)非同义或剪接位点变异。
先前隐匿的心肌隐性缺陷可能易导致以AM形式出现的急性心力衰竭,尤其是在儿童常见病毒感染后。